VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
292 hedge funds and large institutions have $7.18B invested in Verona Pharma in 2025 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 81 increasing their positions, 109 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% more funds holding in top 10
Funds holding in top 10: 28 → 29 (+1)
26% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 109
69% less call options, than puts
Call options by funds: $102M | Put options by funds: $328M
Holders
292
Holding in Top 10
29
Calls
$102M
Puts
$328M
Top Buyers
| 1 | +$117M | |
| 2 | +$78M | |
| 3 | +$68.4M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$64.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$59.3M |
Top Sellers
| 1 | -$107M | |
| 2 | -$93.4M | |
| 3 | -$78.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$60.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$37.1M |